A patient is scheduled to receive Pergonal (Menotropins) injections as part of an infertility treatment before in vitro fertilization.
What is the anticipated effect of this medication?

Choice A rationale
Prolongation of the luteal phase is not the primary action of Pergonal (Menotropins). The luteal phase is part of the menstrual cycle, and while hormones do regulate it, Pergonal’s primary function is not to extend this phase.
Choice B rationale
Pergonal (Menotropins) is used to stimulate ovulation. It contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are essential for ovulation. FSH stimulates the growth and maturation of ovarian follicles, and LH triggers ovulation and the development of the corpus luteum.
Choice C rationale
Suppression of menstruation is not an expected action of Pergonal. This medication is used to promote ovulation, not to stop menstrual periods.
Choice D rationale
While hormonal changes during the menstrual cycle can affect cervical mucus production, the primary action of Pergonal is not to promote cervical mucus production. Its main role is to stimulate ovulation.

Choice A rationale
As of my knowledge cutoff in 2021, there is no vaccine available that prevents genital herpes simplex infection from returning.
Choice B rationale
Penicillin is not effective against viral infections such as genital herpes. Antiviral medications are used to manage symptoms and reduce recurrences.
Choice C rationale
This is the most appropriate response. While there is no cure for genital herpes, antiviral medications can help to reduce symptoms and the frequency of recurrences.
Choice D rationale
Having a genital herpes infection does not lead to immunity. The virus remains in the body and can cause recurrent outbreaks.